跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEMAZIN IMMUNE DEFENCE Capsule - TGA Drug Approval Details
Approvals
/
TGA
/
DEMAZIN IMMUNE DEFENCE Capsule
Approved
STANDARD
DEMAZIN IMMUNE DEFENCE Capsule
iNova Pharmaceuticals (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e0442cbe67ed502f
Company
iNova Pharmaceuticals (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
e0442cbe67ed502f
Product Name
DEMAZIN IMMUNE DEFENCE Capsule
Artg Id
345568
Artg Name
DEMAZIN IMMUNE DEFENCE Capsule
Sponsor
iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path
/organization/inova-pharmaceuticals-australia-pty-limited
Artg Date
2020-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e0442cbe67ed502f
Type
Standard
Back to TGA Approvals